This week, the FDA will decide whether to approve Vertex Pharmaceuticals' non-opioid painkiller. Vertex believes pain could ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its fourth quarter and full year 2024 financial results on ...

Leerink Partners analyst David Risinger has reiterated their bullish stance on VRTX stock, giving a Buy rating yesterday.Invest with ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), with its substantial $114.5 billion market capitalization, continues to dominate the cystic fibrosis (CF) treatment market while advancing a ...

Piper Sandler lowered the firm’s price target on Vertex Pharmaceuticals (VRTX) to $533 from $535 and keeps an Overweight rating on the shares ...

Vertex (VRTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Vertex Pharmaceuticals Inc (VRTX) stock saw a decline, ending the day at $439.62 which represents a decrease of $-0.11 or -0.03% from the prior close of $439.73. The stock opened at $438.73 and ...

Piper Sandler made a slight adjustment to the price target of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), bringing it down to $533 from the previous target of $535, while maintaining an ...

Valmet's Shareholders' Nomination Board updates its proposal for the composition and remuneration of the Board of Directors Valmet Oyj's stock exchange release on January 27, 2025 at 2:00 p.m. EET ...

Trinity Capital Inc.  ("Trinity Capital"), a leading alternative asset manager, today announced the commitment of $30 million in growth capital to Elucent Medical ("Elucent"), a pioneering medical ...

The website changes raise concerns about “the interference of politics with the study and the practice” of science and medicine, one physician said.

Boston got over 110 inches of snow during the historic 2015 winter — and that wasn't the only wild number. Here’s a look back ...